New study aims to solve the puzzle of COVID-19’s long-term impact
CANCOV is a cross-Canada study that aims to understand why some people get severe disease and the long-term effects of COVID-19
Read MoreJune 11, 2021
CANCOV is a cross-Canada study that aims to understand why some people get severe disease and the long-term effects of COVID-19
Read More
Two out of three Vancouver physicians surveyed in a new CHÉOS study faced burnout during the COVID-19 pandemic
Read More
Featuring some of the latest research from CHÉOS, including physician burnout during COVID-19, treating opioid use disorder, and patient perspectives on the Biosimilars Initiative
Read More
This edition includes major depressive disorder treatment coverage, social connections and hypertension, and paramedic experiences of the overdose response
Read More
After more than 20 years at CHÉOS, Dr. Peter Dodek is set to retire at the end of June. Join us in learning about his fascinating career as a clinician-scientist
Read More
The latest edition summarizes some of the latest research from CHÉOS Scientists Drs. Sarah Munro, Andrea Veljkovic, Anita Palepu, Ehsan Karim, and Anne Gadermann
Read More
The 27th edition summarizes some of the latest research from CHÉOS Scientists, including incarceration and homelessness, adverse events, and societal values related to drug funding.
Read More
Part one of our two-part series for Patient Safety Week features research from CHÉOS Scientist Dr. Rita McCracken.
Read More
The twenty-third instalment of "The Evidence Speaks" Series includes the some of the latest research from CHÉOS Scientists on everything from post-operative protocols to resilience.
Read More
Read about Dr. Nadia Khan's research that investigates chronic disease management and prevention strategies and cardiovascular risk factors related to stroke.
Read More